Company

TropiQ

TropIQ combines world-class parasitological expertise with state of the art drug discovery technologies. Through this combination, TropIQ is uniquely positioned to accelerate the development of malaria-eradicating drugs. The company was founded in 2011 as a spin-off of the Radboud university medical center in the Netherlands (Nijmegen).

TropIQ

Transistorweg 5-C02 (Building M)

6534 AT Nijmegen

The Netherlands

+31 (0)24 3666478i

nfo@tropIQ.nl

Website

More companies in this area

Pleco Therapeutics

Our current pre-clinical development programs focus on the development of treatments for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer.

GCP-Service International

GCP-Service International is a mid-size contract research organization (CRO), with branches across Germany, Netherlands, Poland and Czech Republic.

DFE Pharma

DFE Pharma develops, produces and supplies excipients for use in oral solid dose and dry powder inhalation,

Vaxxinova

Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!